Drugs / MTX228
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT06474598 Comparator | Nov 2024 → Oct 2026 expected | type 1 diabetes mellitus | University of Alberta | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MTX228 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06474598 ↗ |
| Route | Oral | “oral tablet administration of MTX228” NCT06474598 ↗ |